Log in


0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $13.67
50-Day Range
MA: $11.97
52-Week Range
Now: $13.67
Average Volume100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Harvey Norman Holdings Limited grants franchises to independent franchisees. Its franchisees sell products in various categories, including electrical goods, furniture, computers and communications, bedding and manchester, kitchen appliances, small appliances, bathroom and tiles, and carpets and flooring. The company has 195 franchised complexes under the Harvey Norman, Domayne, and Joyce Mayne brands in Australia; and 89 company-operated stores under the Harvey Norman brand in New Zealand, Ireland, Northern Ireland, Singapore, Malaysia, Slovenia, and Croatia. It is also involved in the property investment and media placement activities, as well as provides consumer finance and other commercial loans and advances. The company was founded in 1982 and is based in Homebush West, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Department Stores
Phone61 2 9201 6111



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive HNORY News and Ratings via Email

Sign-up to receive the latest news and ratings for HNORY and its competitors with MarketBeat's FREE daily newsletter.

HARVEY NORMAN H/ADR (OTCMKTS:HNORY) Frequently Asked Questions

How has HARVEY NORMAN H/ADR's stock been impacted by COVID-19 (Coronavirus)?

HARVEY NORMAN H/ADR's stock was trading at $16.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HNORY shares have decreased by 15.7% and is now trading at $13.67. View which stocks have been most impacted by Coronavirus.

Has HARVEY NORMAN H/ADR been receiving favorable news coverage?

News coverage about HNORY stock has been trending neutral this week, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. HARVEY NORMAN H/ADR earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about HARVEY NORMAN H/ADR.

Who are some of HARVEY NORMAN H/ADR's key competitors?

Who are HARVEY NORMAN H/ADR's key executives?

HARVEY NORMAN H/ADR's management team includes the following people:
  • Mr. Gerald Harvey, Co-Founder, Exec. Chairman & Head of Strategy (Age 80)
  • Ms. Kay Lesley Harvey Page, CEO & Exec. Director (Age 62)
  • Mr. Chris Mentis BBus, FCA, GradDipAppFin, FGIA, CFO, Company Sec. & Exec. Director (Age 53)
  • Mr. John Evyn Slack-Smith, COO & Exec. Director (Age 50)
  • Frank Robinson, Gen. Mang. of Technology & Entertainment

What is HARVEY NORMAN H/ADR's stock symbol?

HARVEY NORMAN H/ADR trades on the OTCMKTS under the ticker symbol "HNORY."

How do I buy shares of HARVEY NORMAN H/ADR?

Shares of HNORY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HARVEY NORMAN H/ADR's stock price today?

One share of HNORY stock can currently be purchased for approximately $13.67.

What is HARVEY NORMAN H/ADR's official website?

The official website for HARVEY NORMAN H/ADR is www.harveynormanholdings.com.au.

How can I contact HARVEY NORMAN H/ADR?

The company can be reached via phone at 61 2 9201 6111.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.